BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ERG, P11308, 2078
23 results:

  • 1. Synchronous Double Primary Angiosarcoma Originating from the Stomach and Rectum: A Case Report and a Literature Review.
    Kapagan T; Bulut N; Erdem GU; Yıldırım S; Erdem ZB; Sahin H
    Arch Iran Med; 2024 Mar; 27(3):168-173. PubMed ID: 38685842
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Intercellular adhesion molecule 2 as a novel prospective tumor suppressor induced by erg promotes ubiquitination-mediated radixin degradation to inhibit gastric cancer tumorigenicity and metastasis.
    Tang X; Huang J; Jiang Y; Qiu J; Li T; Li W; Chen Z; Huang Z; Yu X; Yang T; Ji X; Tan R; Lv L; Yang Z; Chen H
    J Transl Med; 2023 Sep; 21(1):670. PubMed ID: 37759298
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epigenetic and Tumor Microenvironment for Prognosis of Patients with gastric cancer.
    Wu Z; Wang W; Zhang K; Fan M; Lin R
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238607
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Analysis of Prognostic Risk Factors of Endoscopic Submucosal Dissection (ESD) and Curative Resection of Gastrointestinal Neuroendocrine Neoplasms.
    Si Y; Huang C; Yuan J; Zhang X; He Q; Lin Z; He L; Liu Z
    Contrast Media Mol Imaging; 2022; 2022():5248256. PubMed ID: 35854772
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and TLS-erg gene fusion: A case report.
    Gao L; Xu Y; Tian Z; Xia J; Yuan Z; Chen D; Ren M
    Medicine (Baltimore); 2022 May; 101(21):e29475. PubMed ID: 35623083
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Case of cystoid macular edema induced by systemic administration of paclitaxel: evaluations with electroretinograms.
    Kato K; Nagashima R; Sugimoto M; Ikesugi K; Matsubara H; Kondo M
    Doc Ophthalmol; 2021 Oct; 143(2):229-235. PubMed ID: 33842988
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression.
    Shang W; Wang Y; Liang X; Li T; Shao W; Liu F; Cui X; Wang Y; Lv L; Chai L; Qu L; Zheng L; Jia J
    J Pathol; 2021 Feb; 253(2):148-159. PubMed ID: 33044755
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
    Naderi A
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Perigastric solitary fibrous tumor (SFT) diagnosed on fine needle aspiration: A case report and review of literature.
    Ababneh E; Policarpio-Nicolas MLC
    Diagn Cytopathol; 2020 Dec; 48(12):E27-E32. PubMed ID: 32628336
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy.
    Fu J; Tang L; Li ZY; Li XT; Zhu HF; Sun YS; Ji JF
    Eur J Radiol; 2020 Jul; 128():108974. PubMed ID: 32416553
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Ets-1 promoter-associated noncoding RNA regulates the NONO/erg/Ets-1 axis to drive gastric cancer progression.
    Li D; Chen Y; Mei H; Jiao W; Song H; Ye L; Fang E; Wang X; Yang F; Huang K; Zheng L; Tong Q
    Oncogene; 2018 Aug; 37(35):4871-4886. PubMed ID: 29773901
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The poor prognosis of the primary gastric epithelioid angiosarcoma: A case report.
    Xia J; Shi D; Wu Z; Chen Y; Liu B; Chen L; Metta W; Zheng Y
    Medicine (Baltimore); 2018 Apr; 97(15):e0287. PubMed ID: 29642150
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ramucirumab for Treating Advanced gastric cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Büyükkaramikli NC; Blommestein HM; Riemsma R; Armstrong N; Clay FJ; Ross J; Worthy G; Severens J; Kleijnen J; Al MJ
    Pharmacoeconomics; 2017 Dec; 35(12):1211-1221. PubMed ID: 28656543
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. ergosterol-loaded poly(lactide-co-glycolide) nanoparticles with enhanced in vitro antitumor activity and oral bioavailability.
    Zhang HY; Firempong CK; Wang YW; Xu WQ; Wang MM; Cao X; Zhu Y; Tong SS; Yu JN; Xu XM
    Acta Pharmacol Sin; 2016 Jun; 37(6):834-44. PubMed ID: 27133301
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.
    Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
    APMIS; 2016 Apr; 124(4):263-70. PubMed ID: 26778368
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution.
    Misirlioglu HC; Coskun-Breuneval M; Kucukpilakci B; Ugur VI; Elgin Y; Demirkasimoglu T; Kara SP; Ozgen A; Sanri E; Guney Y
    Asian Pac J Cancer Prev; 2014; 15(20):8871-6. PubMed ID: 25374221
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The mechanism of COX-2 regulating Herg channel in gastric cancer cells.
    Shao XD; Guo XZ; Ren LN; Lin H
    Bratisl Lek Listy; 2014; 115(8):487-91. PubMed ID: 25246284
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Intravenous iron supplementation may be superior to observation in acute isovolemic anemia after gastrectomy for cancer.
    Yoon HM; Kim YW; Nam BH; Reim D; Eom BW; Park JY; Ryu KW
    World J Gastroenterol; 2014 Feb; 20(7):1852-7. PubMed ID: 24587663
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Trastuzumab for the treatment of HER2-positive metastatic gastric cancer : a NICE single technology appraisal.
    Spackman E; Rice S; Norman G; Suh DC; Eastwood A; Palmer S
    Pharmacoeconomics; 2013 Mar; 31(3):185-94. PubMed ID: 23371465
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.
    Norman G; Rice S; Spackman E; Stirk L; Danso-Appiah A; Suh D; Palmer S; Eastwood A
    Health Technol Assess; 2011 May; 15 Suppl 1():33-42. PubMed ID: 21609651
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.